(Q45714279)

English

Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy

scientific article published in February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

0 references

author name string

Susanne Frank

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sabine Steffens

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Ute Fischer

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Aurelia Tlolko

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Nikolai G Rainov

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Christof M Kramm

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

178-188

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700422

0 references

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

21 January 2018

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

21 January 2018

An experimental model of retrovirus gene therapy for malignant brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

21 January 2018

Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

21 January 2018

New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

21 January 2018

Enhanced green fluorescent protein fusion proteins of herpes simplex virus type 1 thymidine kinase and cytochrome P450 4B1: applications for prodrug-activating gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

21 January 2018

CYP4B1 activates 4-ipomeanol in rat lung

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

21 January 2018

4-Ipomeanol and 2-aminoanthracene cytotoxicity in C3H/10T1/2 cells expressing rabbit cytochrome P450 4B1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

21 January 2018

Tumor cell endocytosis imaging facilitates delineation of the glioma-brain interface.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

21 January 2018

The biochemistry and mechanism of action of acyclovir

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

21 January 2018

Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

21 January 2018

Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

21 January 2018

Necrotic, rather than apoptotic, cell death caused by cytochrome P450-activated ifosfamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

21 January 2018

Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

21 January 2018

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

21 January 2018

Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

21 January 2018

Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

21 January 2018

Herpes simplex thymidine kinase (HStk) transgenic donor lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

21 January 2018

Gene therapy for brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

7 January 2021

based on heuristic

inferred from DOI database lookup

A chimeric fusion protein of cytochrome CYP4B1 and green fluorescent protein for detection of pro-drug activating gene delivery and for gene therapy in malignant glioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

7 January 2021

based on heuristic

inferred from DOI database lookup

The 9L rat brain tumor: Description and application of an animal model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: a phase I-II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700422

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700422

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45714279&oldid=2077711618"